|
Status |
Public on Dec 09, 2023 |
Title |
ESR1-WT_shESR1_ICI3 |
Sample type |
SRA |
|
|
Source name |
T47D shESR1
|
Organism |
Homo sapiens |
Characteristics |
cell line: T47D shESR1 cell type: No special type breast cancer cell line genotype: ESR1-WT treatment: ICI duration: 24hr
|
Treatment protocol |
Biological triplicates of each cell line were treated with 100µM fulvestrant (#1047, Tocris) dissolved in 100% ethanol or equal volume 100% ethanol for 24 hours.
|
Growth protocol |
Cells were grown in RPMI-1640 (#11875-119, Life Technologies) media at 37 °C and 5% CO2 before three days of hormone deprivation (media change to improved MEM (#MT10026CV, Fisher Scientific) supplemented with 10% CSS). Cells were seeded into 6 well plates and allowed to adhere overnight before the 24-hour treatment.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA extracted with Qiagen RNeasy Kit following manufacturer's instructions. RNA sequencing library construction, quality control, and paired-end sequencing were performed by the UPMC Genome Center (Pittsburgh, Pennsylvania) according to their protocol.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NovaSeq 6000 |
|
|
Description |
WT_ICI3
|
Data processing |
RStudio Version 4.0.0 Transcript counts were quantified using Salmon v1.3.0 with parameters --seqBias --gcBias -p 8 -o and index hg38. Gene-level counts were generated using tximport (Soneson et al., 2015) version 1.18.0. Differential gene expression analysis was performed using the DESeq2 package version 1.30.1. Assembly: hg38 Supplementary files format and content: Tab-delimited text files including tximport abundance, count and lengths for each gene in each sample.
|
|
|
Submission date |
Dec 08, 2023 |
Last update date |
Dec 09, 2023 |
Contact name |
Megan E. Yates |
Organization name |
University of Pittsburgh
|
Lab |
Lee-Oesterreich Lab
|
Street address |
5051 Centre Ave
|
City |
Pittsburgh |
State/province |
PA |
ZIP/Postal code |
15213 |
Country |
USA |
|
|
Platform ID |
GPL24676 |
Series (2) |
GSE249723 |
ESR1 fusions invoke breast cancer subtype-dependent enrichment of ligand independent oncogenic signatures and phenotypes [RNA-seq] |
GSE266408 |
ESR1 fusions invoke breast cancer subtype-dependent enrichment of ligand independent oncogenic signatures and phenotypes |
|
Relations |
BioSample |
SAMN38739338 |
SRA |
SRX22839697 |